Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Tue, 09 Jun 2026 12:11:14 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngPeptiSystems appoints Ida Nordberg as CFOhttps://news.cision.com/peptisystems-ab/r/peptisystems-appoints-ida-nordberg-as-cfo,c4357995cision5379665Tue, 09 Jun 2026 06:05:00 GMTElicera’s Nomination Committee Proposes Margareth Jorvid as New Chair of the Boardhttps://news.cision.com/elicera-therapeutics/r/elicera-s-nomination-committee-proposes-margareth-jorvid-as-new-chair-of-the-board,c4358861cision5378923Mon, 08 Jun 2026 06:40:00 GMTCurasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT[®] in Aggressive Brain Cancer (Glioblastoma)https://news.cision.com/curasight/r/curasight-announces-preliminary-readout-from-its-phase-1-clinical-trial-with-utreat--in-aggressive-b,c4358770cision5378678Mon, 08 Jun 2026 05:05:00 GMTNavinci to Showcase Omni at EACR 2026https://news.cision.com/navinci/r/navinci-to-showcase-omni-at-eacr-2026,c4358410cision5378278Fri, 05 Jun 2026 08:15:00 GMTPharmability submits Clinical Trial Application for first-in-human Phase Ib study of TIR-C in atopic dermatitishttps://news.cision.com/pharmability-ab/r/pharmability-submits-clinical-trial-application-for-first-in-human-phase-ib-study-of-tir-c-in-atopic,c4357814cision5378047Fri, 05 Jun 2026 05:30:00 GMTResolutions passed at Bio-Works Technologies’ annual general meeting 2026https://news.cision.com/bio-works-technologies-ab/r/resolutions-passed-at-bio-works-technologies--annual-general-meeting-2026,c4355858cision5377595Thu, 04 Jun 2026 08:20:00 GMTElicera publishes annual report for 2025https://news.cision.com/elicera-therapeutics/r/elicera-publishes-annual-report-for-2025,c4355948cision5376696Wed, 03 Jun 2026 15:01:00 GMTChanges in UPM’s Group Executive Team: Joonas Rauramo appointed Executive Vice President, UPM Energyhttps://news.cision.com/upm-kymmene-oyj/r/changes-in-upm-s-group-executive-team--joonas-rauramo-appointed-executive-vice-president--upm-energy,c4356924cision5376143Wed, 03 Jun 2026 07:00:00 GMTHansa Biopharma participating in Jefferies Global Healthcare Conference in New Yorkhttps://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-participating-in-jefferies-global-healthcare-conference-in-new-york,c4356470cision5375328Tue, 02 Jun 2026 10:35:00 GMTAAX Biotech announces collaboration with research group at Karolinska Institutet on high-throughput characterization of novel TROP2-targeting antibodieshttps://news.cision.com/aax-biotech-ab/r/aax-biotech-announces-collaboration-with-research-group-at-karolinska-institutet-on-high-throughput-,c4356042cision5374853Tue, 02 Jun 2026 05:30:00 GMTCHOSA and AIDA present data at ASCO 2026 showing up to 78% pathological complete response (pCR) rate in breast cancer using combined, integrated, taxane and platinum biomarkershttps://news.cision.com/chosa-oncology-ab/r/chosa-and-aida-present-data-at-asco-2026-showing-up-to-78--pathological-complete-response--pcr--rate,c4355574cision5374799Mon, 01 Jun 2026 18:30:00 GMTCHOSA presents data at ASCO validating Platin-DRP on the NanoString platform showing significant overall survival prediction in Phase III lung cancer studyhttps://news.cision.com/chosa-oncology-ab/r/chosa-presents-data-at-asco-validating-platin-drp-on-the-nanostring-platform-showing-significant-ove,c4355578cision5374802Mon, 01 Jun 2026 18:30:00 GMTElicera announces outcome of the rights issuehttps://news.cision.com/elicera-therapeutics/r/elicera-announces-outcome-of-the-rights-issue,c4356112cision5374745Mon, 01 Jun 2026 15:46:00 GMTBulletin from the Annual General Meeting in Hansa Biopharma AB (publ)https://news.cision.com/hansa-biopharma-ab/r/bulletin-from-the-annual-general-meeting-in-hansa-biopharma-ab--publ-,c4356071cision5374705Mon, 01 Jun 2026 15:00:00 GMTVitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi’s retirementhttps://news.cision.com/vitrolife-ab--publ-/r/vitrolife-group-appoints-olivier-desmarets-as-chief-operations-officer-following-ermanno-sironi-s-re,c4355088cision5374381Mon, 01 Jun 2026 10:00:00 GMTHansa Biopharma’s CEO Renée Aguiar-Lucander named one of Sweden’s Most Influential Business Women of 2026https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-s-ceo-renee-aguiar-lucander-named-one-of-sweden-s-most-influential-business-women-of,c4354847cision5372955Fri, 29 May 2026 05:00:00 GMTArcticZymes Technologies Strengthens Board with Appointment of Dr. Hanna Pirita Lesch, Supporting Diversification into RNA and Continued Leadership in Cell & Gene Therapyhttps://news.cision.com/arcticzymes-technologies/r/arcticzymes-technologies-strengthens-board-with-appointment-of-dr--hanna-pirita-lesch--supporting-di,c4354775cision5372734Thu, 28 May 2026 13:02:00 GMTPublication of interim report January – March 2026https://news.cision.com/genetic-analysis-as/r/publication-of-interim-report-january---march-2026,c4354373cision5372300Thu, 28 May 2026 06:45:00 GMTInside information: UPM and Sappi have signed a definitive agreement on the graphic paper Joint Venturehttps://news.cision.com/upm-kymmene-oyj/r/inside-information--upm-and-sappi-have-signed-a-definitive-agreement-on-the-graphic-paper-joint-vent,c4353868cision5372228Thu, 28 May 2026 06:27:24 GMTInterim Report first quarter 2026https://news.cision.com/nextcell-pharma-ab/r/interim-report-first-quarter-2026,c4354059cision5372073Thu, 28 May 2026 05:45:00 GMTNew JNM publication strengthens the scientific foundation for AKIR001https://news.cision.com/akiram-therapeutics/r/new-jnm-publication-strengthens-the-scientific-foundation-for-akir001,c4354117cision5372014Thu, 28 May 2026 05:03:00 GMTInterim report Q1 2026https://news.cision.com/curasight/r/interim-report-q1-2026,c4354283cision5372007Thu, 28 May 2026 05:00:00 GMTBulletin from the annual general meeting on 27 May 2026 in Chosa Oncology ABhttps://news.cision.com/chosa-oncology-ab/r/bulletin-from-the-annual-general-meeting-on-27-may-2026-in-chosa-oncology-ab,c4354037cision5371714Wed, 27 May 2026 12:40:38 GMTNextCell Pharma AB (publ) Annual General Meeting 2026https://news.cision.com/nextcell-pharma-ab/r/nextcell-pharma-ab--publ--annual-general-meeting-2026,c4353219cision5371623Wed, 27 May 2026 12:00:00 GMT